PEOPLE - Kalibrant (UK) makes appointment:
This article was originally published in Clinica
Executive Summary
Automated biosystems company Kalibrant (Loughborough, UK) has appointed Nick Pay as chief executive. Dr Pay joins the company, which develops devices and reagents based on flow injection analysis, from Roche Diagnostics, where he was senior vice-president of strategic planning. Dr Pay's remit will include setting up commercial partnerships to bring the company's core Jetstream technology to market.